aclacinomycin has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duverger, A; Jones, J; Kappes, J; Kutsch, O; Shishido, T; Wagner, F; Wolschendorf, F | 1 |
1 other study(ies) available for aclacinomycin and HIV Coinfection
Article | Year |
---|---|
Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.
Topics: Aclarubicin; Anti-HIV Agents; Cell Differentiation; Cell Line; Dactinomycin; Drug Evaluation, Preclinical; HIV Infections; HIV-1; Humans; T-Lymphocytes; Virus Activation; Virus Latency | 2012 |